IMIQUIMOD for Squamous cell carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 39 adverse event reports in the FDA FAERS database where IMIQUIMOD was used for Squamous cell carcinoma.
Most Reported Side Effects for IMIQUIMOD
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 264 | 15.6% | 4 | 15 |
| Product use in unapproved indication | 179 | 10.6% | 0 | 4 |
| Erythema | 171 | 10.1% | 1 | 14 |
| Drug ineffective | 123 | 7.3% | 2 | 9 |
| Fatigue | 118 | 7.0% | 3 | 12 |
| Influenza like illness | 101 | 6.0% | 0 | 13 |
| Pain | 98 | 5.8% | 0 | 3 |
| Application site erythema | 95 | 5.6% | 0 | 3 |
| Nausea | 90 | 5.3% | 4 | 15 |
| Headache | 79 | 4.7% | 3 | 11 |
| Scab | 73 | 4.3% | 1 | 6 |
| Pruritus | 72 | 4.3% | 1 | 4 |
| Application site pain | 68 | 4.0% | 1 | 4 |
| Pyrexia | 62 | 3.7% | 1 | 10 |
| Chills | 56 | 3.3% | 1 | 12 |
Other Indications for IMIQUIMOD
Actinic keratosis (331)
Basal cell carcinoma (276)
Product used for unknown indication (170)
Anogenital warts (86)
Skin papilloma (74)
Skin cancer (57)
Precancerous skin lesion (48)
Squamous cell carcinoma of skin (45)
Molluscum contagiosum (36)
Metastatic malignant melanoma (34)
Other Drugs Used for Squamous cell carcinoma
CARBOPLATIN (608)
CISPLATIN (522)
PACLITAXEL (496)
PEMBROLIZUMAB (470)
FLUOROURACIL (430)
NIVOLUMAB (343)
CETUXIMAB (283)
CEMIPLIMAB-RWLC (234)
DOCETAXEL (198)
GEMCITABINE (109)